These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9275421)

  • 1. [Three dimensional reconstruction of human endometrial spiral arteries preinsertion and postinsertion of IUD].
    Huang L; Chen L; Chen Q
    Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):523-5. PubMed ID: 9275421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The morphometric study of endometrial spiral arterioles before and after insertion of gamma CuI and TCu 220C intrauterine devices].
    Liu Z; Chen Q; Ni X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):232-4. PubMed ID: 10682472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medicated stainless steel ring-165, medicated gamma-intrauterine devices and TCu220C: a multicenter comparative study].
    Zhuang L; Yang B; Yuan H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Feb; 32(2):97-101. PubMed ID: 9596880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The morphometric study of endometrium during long-term use of TCu220C IUD].
    Zhao Y; He Q
    Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):519-22. PubMed ID: 9275420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
    Pan J; Yu Y; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of intrauterine contraceptive device on expression of vascular endothelial growth factor, kinase insert domain-containing receptor and microvessel density in endometrium].
    Xin ZM; Xie QZ; Cao LM; Sun YP; Su YC; Guo YH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):771-5. PubMed ID: 15634506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary morphometric study on the endometrium from patients treated with indomethacin-releasing copper intrauterine device.
    Zhao G; Li M; Zhu P; Xu R; Wang J; Xu R
    Hum Reprod; 1997 Jul; 12(7):1563-6. PubMed ID: 9262297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the effects of FCu-IUD and FICu-IUD on matrix metalloproteinases in human uterine flushing and endometrium.
    Li W; Cao L; Chen Z; Li W; Du Q; Chen G
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):9-11, 16. PubMed ID: 12658770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine devices.
    Yin M; Zhu P; Luo H; Xu R
    Contraception; 1993 Sep; 48(3):245-54. PubMed ID: 8222654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endometrial histology studied in women bleeding with IUD in situ].
    Nesit V; Kyselá T
    Cesk Gynekol; 1975 Jul; 40(6):427-31. PubMed ID: 1157133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term clinical observation on VCu200 intrauterine devices].
    Wu XZ; Lu J; Li HQ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):545-7, 544-5. PubMed ID: 7835133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
    Ozalp S; Kabukcuoglu S; Tanir HM
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endometrial cytology with a new copper-containing IUD (ML Cu 250) (proceedings)].
    Herting W; Tauber PF; Kurz E
    Arch Gynakol; 1977 Jul; 224(1-4):34-5. PubMed ID: 579844
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progestasert and copper-T. A prospective, randomized clinical study of 2 coil types].
    Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sørensen T; Westergaard JG
    Ugeskr Laeger; 1980 Dec; 143(1):13-4. PubMed ID: 7018042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of long-term installation of intrauterine devices on intrauterine microenvironment].
    Dong BH; Hou GH; Zhang YZ; Fan J; Zhang P; Li L; Luo X
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):823-6. PubMed ID: 12895331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.